Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia

Jacopo F. Imberti, Katherine Underwood, Andrea Mazzanti, Silvia G. Priori

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inheritable cardiac disorder associated with exercise- and stress-induced sudden death in young individuals.Although important steps forward have been made in the comprehension and treatment of this disease, several aspects remain unclear. Firstly, from an epidemiological standpoint the actual prevalence of CPVT is still unknown and possibly underestimated. In addition, the diagnostic process remains very challenging and can be supported by genetic analysis in only about half of the cases. Finally, up to one third of CPVT patients continue to present complex arrhythmias despite beta-blocker treatment; the role of newer therapeutic options, such as flecainide and left cardiac sympathetic denervation, needs to be further elucidated. All these points constitute challenges for the cardiologist in the management of CPVT patients and fuel research into new diagnostic, prognostic and therapeutic approaches.

Original languageEnglish
JournalHeart Lung and Circulation
DOIs
Publication statusPublished - 2016

Fingerprint

Flecainide
Sympathectomy
Therapeutics
Sudden Death
Cardiac Arrhythmias
Exercise
Polymorphic catecholergic ventricular tachycardia
Research
Cardiologists

Keywords

  • Bidirectional ventricular tachycardia
  • CASQ2
  • Catecholaminergic polymorphic ventricular tachycardia
  • Flecainide
  • RyR2
  • Sudden cardiac death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine

Cite this

Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia. / Imberti, Jacopo F.; Underwood, Katherine; Mazzanti, Andrea; Priori, Silvia G.

In: Heart Lung and Circulation, 2016.

Research output: Contribution to journalArticle

@article{9b71a10f8d654bd5ac4d2c3db485b66f,
title = "Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia",
abstract = "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inheritable cardiac disorder associated with exercise- and stress-induced sudden death in young individuals.Although important steps forward have been made in the comprehension and treatment of this disease, several aspects remain unclear. Firstly, from an epidemiological standpoint the actual prevalence of CPVT is still unknown and possibly underestimated. In addition, the diagnostic process remains very challenging and can be supported by genetic analysis in only about half of the cases. Finally, up to one third of CPVT patients continue to present complex arrhythmias despite beta-blocker treatment; the role of newer therapeutic options, such as flecainide and left cardiac sympathetic denervation, needs to be further elucidated. All these points constitute challenges for the cardiologist in the management of CPVT patients and fuel research into new diagnostic, prognostic and therapeutic approaches.",
keywords = "Bidirectional ventricular tachycardia, CASQ2, Catecholaminergic polymorphic ventricular tachycardia, Flecainide, RyR2, Sudden cardiac death",
author = "Imberti, {Jacopo F.} and Katherine Underwood and Andrea Mazzanti and Priori, {Silvia G.}",
year = "2016",
doi = "10.1016/j.hlc.2016.01.012",
language = "English",
journal = "Heart Lung and Circulation",
issn = "1443-9506",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia

AU - Imberti, Jacopo F.

AU - Underwood, Katherine

AU - Mazzanti, Andrea

AU - Priori, Silvia G.

PY - 2016

Y1 - 2016

N2 - Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inheritable cardiac disorder associated with exercise- and stress-induced sudden death in young individuals.Although important steps forward have been made in the comprehension and treatment of this disease, several aspects remain unclear. Firstly, from an epidemiological standpoint the actual prevalence of CPVT is still unknown and possibly underestimated. In addition, the diagnostic process remains very challenging and can be supported by genetic analysis in only about half of the cases. Finally, up to one third of CPVT patients continue to present complex arrhythmias despite beta-blocker treatment; the role of newer therapeutic options, such as flecainide and left cardiac sympathetic denervation, needs to be further elucidated. All these points constitute challenges for the cardiologist in the management of CPVT patients and fuel research into new diagnostic, prognostic and therapeutic approaches.

AB - Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inheritable cardiac disorder associated with exercise- and stress-induced sudden death in young individuals.Although important steps forward have been made in the comprehension and treatment of this disease, several aspects remain unclear. Firstly, from an epidemiological standpoint the actual prevalence of CPVT is still unknown and possibly underestimated. In addition, the diagnostic process remains very challenging and can be supported by genetic analysis in only about half of the cases. Finally, up to one third of CPVT patients continue to present complex arrhythmias despite beta-blocker treatment; the role of newer therapeutic options, such as flecainide and left cardiac sympathetic denervation, needs to be further elucidated. All these points constitute challenges for the cardiologist in the management of CPVT patients and fuel research into new diagnostic, prognostic and therapeutic approaches.

KW - Bidirectional ventricular tachycardia

KW - CASQ2

KW - Catecholaminergic polymorphic ventricular tachycardia

KW - Flecainide

KW - RyR2

KW - Sudden cardiac death

UR - http://www.scopus.com/inward/record.url?scp=84959267575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959267575&partnerID=8YFLogxK

U2 - 10.1016/j.hlc.2016.01.012

DO - 10.1016/j.hlc.2016.01.012

M3 - Article

AN - SCOPUS:84959267575

JO - Heart Lung and Circulation

JF - Heart Lung and Circulation

SN - 1443-9506

ER -